Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN86603231Phase 2Completed
Phase 2, randomised trial of oxantel in trichuriasis (7 arms), sponsored by Fonds national suisse de la recherche scientifique. Primary endpoints: Cure rate against Trichuris trichiura, Egg reduction rate against Trichuris trichiura and 1 more. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN86603231.